[VIR] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[VIR] Vir Biotechnology, Inc.
Announcement Date
19-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -42.40%
YoY- -44.41%
Quarter Report
VIR's Result
VIR's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 66,269 487 371 237 86 17 6 49777.33%
PBT -31,121 -77,224 -63,622 -48,327 -33,909 -28,670 -26,373 11.67%
Tax 46 16 149 -13 19 -2,245 20 74.33%
NP -31,167 -77,240 -63,771 -48,314 -33,928 -28,670 -26,393 11.73%
Tax Rate - - - - - - - -
Total Cost 97,436 77,727 64,142 48,551 34,014 28,687 26,399 139.01%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -47.03 -15,860.37 -17,188.95 -20,385.65 -39,451.16 -168,647.06 -439,883.33 -99.77%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.27 -0.71 -0.69 -0.44 -0.31 -0.30 -0.27 0.00%
EPS Diluted -0.27 -0.71 -0.69 -0.44 -0.31 -0.30 -0.27 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.